Rosen Law Firm said purchasers of Park Ha Biological Technology Co., Ltd. securities between December 27, 2024 and July 8, 2025 have until September 28, 2026 to seek appointment as lead plaintiff in a class action that has already been filed. The firm said investors may be entitled to compensation without paying out-of-pocket fees or costs through a contingency fee arrangement. The lawsuit alleges Park Ha, listed on NASDAQ under PHH and BYAH, made materially false or misleading statements and failed to disclose that it was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals, while omitting the false rumors and artificial trading activity that allegedly drove its stock price. The complaint also alleges the company’s IPO was intentionally structured with an extremely low public float to enable the manipulation scheme, leaving its positive statements about business, operations and prospects misleading or without a reasonable basis. Rosen Law said investors can join the class action online, by phone, or by email, and noted that no class has yet been certified, meaning investors are not represented by counsel unless they retain one.